Suomija – Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos – Antibacterial and antimycobacterial products for systemic use

Suomija – Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos – Antibacterial and antimycobacterial products for systemic use


I dalis: Perkančioji organizacija

    I.1) Pavadinimas ir adresai:

      Oficialus pavadinimas: Finnish Institute for Health and Welfare
      Adresas: P. O. BOX 30
      Miestas: Helsinki
      Pašto kodas: 00271
      Šalis: Suomija
      Asmuo ryšiams:
      El-paštas: kilpailutus@thl.fi
      Interneto adresas (-ai):
      Pagrindinis adresas: https://thl.fi/en/web/thlfi-en

II dalis: Objektas

    II.1.1) Pavadinimas:

      Antibacterial and antimycobacterial products for systemic use
      Nuorodos numeris: THL/5372/2.02.06/2024

    II.1.2) Pagrindinis BVPŽ kodas:

      33651000 Farmacijos produktai ;

    II.1.3) Sutarties tipas:

      Kita
;

    II.1.4) Trumpas aprašymas:

      Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Antibacterial and antimycobacterial products for systemic use" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in ten (10) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Linezolid 2 mg/ml (300 ml, i.v. solution, ATC J01XX08) LOT 2: Pyrazinamide 500 mg (tablet/capsule, oral, ATC J04AK01) LOT 3: Etambuthol 500 mg (tablet/capsule, oral, ATC J04AK02) LOT 4: Clindamycin 300 mg (tablet/capsule, oral, ATC J01FF01) LOT 5: Isoniazide 300 mg (tablet/capsule, oral, ATC J04AC01) LOT 6: Claritromycin 250 mg (tablet/capsule, oral, ATC J01FA09) LOT 7: Clindamycin 15 mg/ml (80 ml, oral suspension, ATC J01FF01) LOT 8: Moxifloxacin 400 mg (tablet/capsule, oral, ATC J01MA14) LOT 9: Levofloxacin 500 mg (tablet/capsule, oral, ATC J01MA12) LOT 10: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products is described in Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Description of the rotation Annex 2.1 Quality scoring table Annex 3 Contract Annex 4 Security annex Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Confidentiality commitment Annex 7 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.

    II.2) Aprašymas:

    II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

      33651000 Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos
      33600000 Farmacijos produktai
Svetainė yra atnaujinama. Galimi smulkūs nesklandumai.